Glucose Health Inc. (GLUC)

[Altitrade Partners]

The reason for the pattern is simple.

Part of the financing deal in May was the retirement of approximately $160,000 in remaining toxic debt, which was convertible at a price of $0.008 per share by the holder of the note.

This was absolutely necessary to avoid the potential for massive share dilution in the future, and something that the new investors were obviously very concerned about

Just prior to the new investor group coming in to provide working capital, and pay off the convertible note, the holder was able to do a small conversion at the $0.008 price.

Those $0.008 shares, most likely, represent the shares that are now being sold into the market during any attempt at a sustainable rally after good news is released.

Once the liquidation of these shares is completed, and the overhead supply removed, GLUC shares should be able rise in price as a result of any new demand for common equity by investors.

These converted shares are merely a short-term impediment, and should be viewed as providing an opportunity for long-term investors to accumulate cheap shares of GLUC for potential future appreciation.